Saturday, March 18, 2006


Hepatitis C Information - NewERListofDxCodes_Eff03 01 06 (2).xls


NewERListofDxCodes_Eff03 01 06 (2).xls
07022 VIRAL HEAPTITIS B WITH HEPATIC COMA CHRONIC WITHOUT MENTION OF H. 07023 VIRAL HEAPTITIS B WITH HEPATIC COMA CHRONIC WITH HEPATITIS DELTA ...

[Immunohistochemical detection of hepatitis C virus antigen from ...
Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041. To investigate the infection of HCV and the expression of HCV antigen (HCAg) ...

viral hepatitis. need advice about viral hepatitis?
... viral hepatiti new items hepatits. viral hpeatitis detailed information hepatiti viral heaptitis purchase with paypal hpeatitis, viral heptaitis order ...

Hepatitis C and Hepatitis B Virus Infection in Different ...
... as risk factors in disease; Next by Date: Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B; ...

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. Bassett SE, Thomas D, Brasky, KM, Lanford RE. 1999. Viral persistence antibody to ...

Hepatitis C Information - Newer Hepatitis B Drug Bests Standard Treatment


Newer Hepatitis B Drug Bests Standard Treatment
Title: Newer Hepatitis B Drug Bests Standard TreatmentCategory: Health NewsCreated: 3/9/2006 1:58:00 AMLast Editorial Review: 3/9/2006 1:58:03 AM

GlobeImmune Recruiting for Clinical Trial
While GlobeImmune's therapeutic vaccine for Hepatitis C is only in Phase Ib of clinical trials, their focus on immunity to the Hepatitis C virus is fascinating. GI-5005 is based on tarmogens being potent activators of antigen-specific immune responses against disease....

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Liver Blood Tests
Title: Liver Blood TestsCategory: Procedures and TestsCreated: 6/2/1998Last Editorial Review: 8/27/2005

Two Studies Recruiting HCV Patients
Sho-saiko-to is the number one liver remedy in Japan. It has been prescribed to over 1.5 million patients (in Japan, doctors medically prescribe certain natural remedies, just like doctors prescribe pharmaceutical drugs in the U.S.). Based on the large body...

Friday, March 17, 2006


Hepatitis C Information - VA National Hepatitis C Program


VA National Hepatitis C Program
The Veterans Affairs National Hepatitis C Web site provides information about viral hepatitis for health care providers inside and outside the VA system, ...

MedlinePlus Medical Encyclopedia: Hepatitis C
Hepatitis C infection is caused by hepatitis C virus (HCV). Persons who may be at risk for hepatitis C are those who:. Received a blood transfusion prior to ...

Hepatitis B and C -- familydoctor.org
What are chronic hepatitis B and chronic hepatitis C? ... Hepatitis B and hepatitis C are spread by contact with infected blood or other body fluids of ...

WHO | Hepatitis C
Hepatitis C is a viral infection of the liver which had been referred to as ... The discovery and characterization of the hepatitis C virus (HCV) led to the ...

Hepatitis C: Hepatitis C Council Of Victoria
Hepatitis C News, Information and Resources and Support.

Hepatitis C Information - What is Hepatitis C?(NC)-Hepatitis C is an infectious

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Thursday, March 16, 2006


Hepatitis C Information - The Treatment of H5N1 Avian Influenza Report: Released by Aethlon Medical


The Treatment of H5N1 Avian Influenza Report: Released by Aethlon Medical
[Press Release] Business Wire via Yahoo! Finance - Mar 15 1:05 PM
SAN DIEGO----March 15, 2006--Aethlon Medical, Inc. , a pioneer in developing therapeutic devices for infectious disease, disclosed this afternoon that Chairman and CEO, James A. Joyce, has authored a report entitled; The Treatment of H5N1 Avian Influenza.Save to My Web

National research priorities on diseases stressed
IPP Media - Mar 12 8:29 PM
The Director General of the National Institute for Medical Research (NIMR), Dr Andrew Kitua, has underscored the importance of revising regularly the national research priorities so as to accommodate changes in disease patterns and severity in places over time.Save to My Web

Extraterrestrial propagation of UFOs through the manipulation of space and time with gravity waves
India Daily - Mar 14 5:12 PM
Scientists are just amazed with data they are receiving from the people who are experiencing presence of extraterrestrial UFOs these days. It seems the UFO propagation in recent days are showing further advances. Some experts now say if we can move on with our technologies why can they not advance.Save to My Web

Human Genome Sciences: Challenging the Pegylated Interferons
RedNova - Mar 15 11:32 AM
Interim results of a phase II trial of Human Genome Sciences' Albuferon in combination with ribavirin showed a significant antiviral effect in non-responders at 48 weeks of treatment.Save to My Web

Wednesday, March 15, 2006


Hepatitis C Information - Hepatitis C Info Links - BCCDC: BC Hepatitis Services -


Hepatitis C Info Links - BCCDC: BC Hepatitis Services -
... Viral Hepatitis C. Hepatitis C On-Line training for physicians "Hepatitis C: What Clinicians and Other Health ...

Search AEGIS
... AEGiS-09IAC: Prevalence of viral hepatitis C in Lithuania ...

Reducing Hepatitis C Transmission (PDF)
... HIV/AIDS, Viral Hepatitis C & Sexually Transmissible Infections in Australia ... HIV/AIDS, viral hepatitis C & sexually transmissible infections in Australia ...

VIRAL HEPATITIS C
... VIRAL HEPATITIS C. Anon: The ABCs of hepatitis ...

Hepatitis C Symptoms
Hepatitis c symptoms to discuss with your doctor. ... This article is not intended as a substitute for competent medical advice. Viral Hepatitis C ...

Tuesday, March 14, 2006


Hepatitis C Information - Novelos Therapeutics Closes $15 Million Private Placement


Novelos Therapeutics Closes $15 Million Private Placement
Genetic Engineering News - Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, announced that today, it closed its previously announced private placement resulting in $15.06 million in

Clinical Trial Results Show That Peregrine's First-In-Class Anti-Viral
Medical News Today - Peregrine Pharmaceuticals, Inc. (PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it will present top line data demonstrating that its first-in

euro adhoc: Intercell AG / Financial Figures
VWDNews - Vienna (Austria), March 6, 2006 - Vaccine company Intercell AG (VSE: ICLL) today announced its preliminary 2005 full year results. Intercell?s aggregate annual revenues increased from EUR 4.6 million in 2004 to EUR 8.5 million in 2005, or by 84.9


Hepatitis C Information - Main


Main
- [ Translate this page ] ... HBV-pNq clinically from the serum of the patient with g type´ Viral heaptitis by ~lOmg/K` body weight per day. the seven patients (23´0) among 30 chosen ...

P
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Sien-Sing Yang, Chao-Tien Hsu, ...

[Immunohistochemical detection of hepatitis C virus antigen from ...
Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041. To investigate the infection of HCV and the expression of HCV antigen (HCAg) ...

Personal note: Hepatitis and Health info and news from Personal ...
mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. liver Unit, Cathay General hospital,280 Sec.4,Jen-Ai Rd.,Taipei,Taiwan ...

USDA Funded Projects
... disease distribution will be applied to newly emeerged diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. ...

Monday, March 13, 2006


Hepatitis C Information - Housing Choice Vouchers - HUD


Housing Choice Vouchers - HUD
Can I move and continue to receive housing choice voucher assistance? ... The housing choice voucher program is the federal government's major program for ...

HCV database home page
About this database The Hepatitis C Virus (HCV) database project is funded by the ... The HCV database group strives to present HCV-associated genetic and ...

www.tulane.edu/~dmsander/WWW/335/HCV.html
Similar pages HCV Hepatitis C Anonymous - 12 Steps - Home Page - Hep C Virus ... HCV Hepatitis Anonymous supplies current hepatitis news & information on Hepatitis C (HCV), 12 steps, big book, positive attitudes, online HCV meetings and ...

HCV Wireless
Kompakar & HCV Wireless In Partnership To Launch Fixed-Mobile Convergence ... Alcatel have partnered with HCV Wireless to deliver Fixed Mobile Convergence ...

HCV Advocate Newsletter
The HCV Advocate newsletter is a valuable resource designed to provide the hepatitis C community with monthly updates on events, clinical research, ...

Hepatitis C Information - Hepatitis C - eMedicine Health


Hepatitis C - eMedicine Health
Consumer health resource center providing an overview , the causes, symptoms and treatment.

Hepatitis C Society of Canada - Welcome
Hepatitis C Society of Canada - Welcome

The National Institutes of Health (NIH) Consensus Development Program
Management of Hepatitis C: 2002 National Institutes of Health Consensus Conference Statement June 10-12, 2002 NIH Consensus and State-of-the-Science statements are prepared by

Hepatitis C: An Epidemic for Anyone
Everett Koop, provides extensive information about hepatitis C and the hepatitis c epidemic. Hepatitis C is a life-threatening, blood borne disease of the liver that is far more easily transmitted

Sloan-Kettering - Find a Clinical Trial
Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073]

Hepatitis C Information - The National Institutes of Health (NIH) Consensus Development Program: Management of Hepatitis C


The National Institutes of Health (NIH) Consensus Development Program: Management of Hepatitis C
... non-Hispanic whites (1.5 percent). The incidence of hepatitis C infection appears to be declining since its peak ... The range of disease states following hepatitis C infection is broad ...

Hepatitis C
Hepatitis C. By Howard J. Worman, M. D. The Hepatitis C Virus (HCV) HCV was discovered in 1989 by investigators at Chiron, Inc.

Child Health Resources | Children's Hospital & Regional Medical Center
Explore Children's health information and resources. ... Children with hepatitis C infection need to be monitored ... in some patients; however, many patients relapse after the drug is stopped, and the hepatitis C infection comes back ...

Hepatitis C: An Epidemic for Anyone
Public health awareness site hosted by Dr. C. Everett Koop and providing information about hepatitis C and the hepatitis C epidemic.

Hepatitis C
Hepatitis C. (2 contact hour course) Objectives: Upon completion of this course the student will know the causes, diagnoses, epidemiology and treatment of hepatitis C. ... is a reliable way of demonstrating that hepatitis C infection is present and is the most ... The natural history of chronic hepatitis C infection. European Journal of Gastroenterology ...

Hepatitis C - New Treatment Helps Some, But Cure Remains Elusive - StopGettingSick News
... is no vaccine or other means of preventing hepatitis C infection. HCV exists in many different forms, called genotypes ...

Hepatitis C Information - Hepatitis C: FAQ | CDC Viral Hepatitis


Hepatitis C: FAQ | CDC Viral Hepatitis
Roche has a Hep C Action Newsletter including details about hepatitis C treatments and services see http://www.hepcfight.com/; The Bureau of Primary Health ...

Hep C Palace
Hepatitis C information, chat and support for people with HCV, their friends and family.

hepCuk.info
Natural progression of hep C · Stages of Hepatitis C · Acute Phase · Overview of Chronic Phase · Overview of Compensated Cirrhosis ...

Hepatitis C: Index | CDC Viral Hepatitis
Hep C Connnection: a hepatitis C network and support system; HIV/HCV Co-infection Center of Excellence: a national resource on HIV/HCV co-infection for ...

Hep-C Alert
Details about this nonprofit organization which is dedicated to raising awareness of, and assisting people affected by Hepatitis C. Includes news and Q&As ...

Hepatitis Central, Hep C INFO, Hepatitis Info, HCV Info, Current ...
Hep C Singles Online Over 4500 Singles Looking For Love And Support! House of Mercy · Institute for Professional Development in the Addictions ...

Hepatitis C Information - Hepatitis C Virus Infection Among U.S. Military Personnel: An


Hepatitis C Virus Infection Among U.S. Military Personnel: An
The following are the possible sources of hepatitis C infection. If you can answer "yes" to any of these risk factors and have not previously been tested for hepatitis C, you should

Viropharma Incorporated | Therapeutic Focus | Hepatitis C
Testing for Hepatitis C infection According to the CDC, there are several blood tests that can be done to determine if someone has been infected with HCV

Hepatitis C Infection (Veterans Affairs)
Hepatitis C Infection Background Hepatitis C (HCV) is a single-stranded RNA virus that is transmitted primarily

HepNet - The Hepatitis Information Network - Hepatitis G
Nov. 8, 1996 Hepatitis G Does Not Appear To Affect Hepatitis C Infection . Oct. 4, 1996 Hepatitis G More Common, More Mild Than Hepatitis C . Dialysis patients are at risk of hepatitis G

Diagnosis of Hepatitis C
Several tests for diagnosing hepatitis C infection are available, but since the levels of virus and the liver enzymes fluctuate, one

Liver Injury Associated with Hepatitis C Infection
Liver Injury Associated with Hepatitis C Infection: Is it the Virus or is it the Host?

Hepatitis C Information - HEP C MATCH: Hepatitis C Dating, Hepatitis C information, Hep-C chat, liver specialists, hepatitis c symptoms, ...


HEP C MATCH: Hepatitis C Dating, Hepatitis C information, Hep-C chat, liver specialists, hepatitis c symptoms, ...
At Hep C Match you will meet thousands of ATTRACTIVE, FUN & QUALITY Hepatitis C Singles. You are NOT alone! There are approximately 5,000,000 people, in the United States living with Hepatitis C (and over 120,000,000 worldwide)! At Hep C Match ...

Hepatitis C Virus (HCV): Hep C Support
Learn More About Hepatitis C Virus (HCV) and Hep C Support

The Body: Hepatitis C and HIV
Hepatitis C and HIV, at The Body, the complete HIV/AIDS resource. ... Hep C spreads more easily than HIV through contact with infected blood. In the U.S., about 4 times as many people have Hep C as have HIV ...

Hep-C Quilt
International Hep-C Quilts. The Hep-C quilts are made up of patches submitted by people from all over the world with Hepatitis C. They are sewn together by me, Marie Stern, in my spare time.

Hep C Treatment
... Hep C Treatment. Diagnosed Hepatitis C - Genotype 3a - October 15th 2002 - Treatment Started 27 March 2005 ... my body and wasn't sure what was related to hep C and what wasn't ...

Hepatitis C Information - Coley Pharmaceutical Group Reports Fourth Quarter and Full Year 2005 Financial Results


Coley Pharmaceutical Group Reports Fourth Quarter and Full Year 2005 Financial Results
[Press Release] PR Newswire via Yahoo! Finance - Feb 23 5:31 AM
Coley Pharmaceutical Group, Inc. , a biopharmaceutical company discovering and developing a novel class of drug candidates known as TLR Therapeutics, today reported its financial results for the quarter and year ended December 31, 2005.Save to My Web

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap Conference
RedNova - Feb 13 2:30 AM
NEW YORK, February 13 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals, Ltd. , a biopharmaceutical company developing drugs against hepatitis, announced today that Ron Bentsur, Chief Executive Officer, will present an overview of the Company at The JPMorgan Small Cap Conference in Philadelphia.Save to My Web

Nabi Biopharmaceuticals to Present at the Lehman Brothers Ninth Annual Global Healthcare Conference
RedNova - Mar 03 7:30 AM
BOCA RATON, Fla., March 3 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals announced today that Thomas H.Save to My Web

Novelos Therapeutics Closes $15 Million Private Placement
RedNova - Mar 07 8:45 PM
Novelos Therapeutics, Inc. (OTCBB: NVLT), a bioSave to My Web

Novelos Therapeutics Files SPA with FDA for Phase 3 Development in Lung Cancer
[Press Release] Business Wire via Yahoo! Finance - Mar 08 5:30 AM
NEWTON, Mass.----March 8, 2006--Novelos Therapeutics, Inc. , a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that it has filed a Special Protocol Assessment with the Food and Drug Administration for a single pivotal Phase 3 trial in advanced non-small cell lung cancer, for its lead product NOV-002 in combination with first-line Save to My Web

Hepatitis C Information - Novelos Therapeutics Closes $15 Million Private Placement


Novelos Therapeutics Closes $15 Million Private Placement
International News Service, Australia - Mar 7, 2006... NOV-002 in lung cancer, in addition to our other clinical development programs, including chemotherapy-resistant ovarian cancer and chronic hepatitis C with NOV ...

XTL Biopharmaceuticals to Present at the JPMorgan Small Cap ...
PR Newswire (press release), NY - Feb 13, 2006... of two monoclonal antibodies against the hepatitis C virus - presently in Phase 1 clinical trials in patients with chronic hepatitis C. XTLbio's hepatitis C ...

Highlights of rising and falling US stocks
Investor's Business Daily (subscription) - Feb 27, 2006... Peregrine Pharmaceuticals Inc. (PPHM) reported positive results related to Tarvacin anti-viral compound in a phase I study of chronic hepatitis C patients. ...

Human Genome Sciences: Human Genome Sciences Reports Financial ...
Webbolt Business News (subscription), Canada - Feb 13, 2006... November 2005, HGS reported the interim results of a Phase 2 trial of Albuferon in combination with ribavirin in patients with chronic hepatitis C who failed ...

Nabi Biopharmaceuticals to Present at the Lehman Brothers Ninth ...
PR Newswire (press release), NY - Mar 3, 2006... to prevent hepatitis C disease in HCV-positive liver transplant patients and is being evaluated for the treatment of chronic hepatitis C virus infections. ...

Hepatitis C Information - Hepatitis C Virus Lives In Your Liver(NC)-Your liver

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>



Hepatitis C Information - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Hepatitis C Information - Infectious Mononucleosis


Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)Category: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 8/31/2005

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Hepatitis C Information - Viral hepatitis C management involves some tough decisions


Viral hepatitis C management involves some tough decisions
Managed Healthcare Executive - From a care delivery standpoint, identifying and treating patients with the hepatitis C virus (HCV) is a complicated and difficult process. It's the most prevalent liver disease in the world, with as many as 300 million people afflicted with the